0 items USD 0.00Search
Your search for "hjresearch global benign prostatic hyperplasia bph treatment industry market research 2019" gave back 1549442 results.
The global Benign Prostatic Hyperplasia (BPH) Laser Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is...
Catalog:
LPI
April 2023
Price: USD 3,660.00
The global Benign Prostatic Hyperplasia (BPH) Laser Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR...
Catalog:
GIR
March 2023
Price: USD 4,480.00
According to our publisher latest study, the global Benign Prostatic Hyperplasia (BPH) Laser Therapy market size was valued at USD million in 2022...
Catalog:
GIR
March 2023
Price: USD 3,480.00
Summary HeyReport estimates that the Benign Prostatic Hyperplasia (BPH) Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD...
Catalog:
HYR
January 2021
Price: USD 2,000.00
Treatment of patients with obstructive benign prostatic hypertrophy (BPH) with the drug Finasteride leads to a moderately improved urinary flow,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Embolization Particle market size was valued at USD 2071 million in 2023 and is forecast to a readjusted size of USD 5142.9 million by...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Benign Prostatic Hyperplasia Therapeutics market size was valued at US$ 6335.7 million in 2023. With growing demand in downstream market,...
Catalog:
LPI
February 2024
Price: USD 3,660.00
A transurethral resection of the prostate (TURP) is a surgical procedure that involves cutting away a section of the prostate. The prostate is a...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Treatment of patients with obstructive benign prostatic hypertrophy (BPH) with the drug Finasteride leads to a moderately improved urinary flow,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Treatment of patients with obstructive benign prostatic hypertrophy (BPH) with the drug Finasteride leads to a moderately improved urinary flow,...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
The global Benign Prostatic Hyperplasia Devices market size was valued at US$ 372.7 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Treatment of patients with obstructive benign prostatic hypertrophy (BPH) with the drug Finasteride leads to a moderately improved urinary flow,...
Catalog:
GIR
January 2023
Price: USD 3,480.00
BPH is an enlarged prostate. The prostate goes through two main growth cycles during a man’s life. The first occurs early in puberty, when the...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Treatment of patients with obstructive benign prostatic hypertrophy (BPH) with the drug Finasteride leads to a moderately improved urinary flow,...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
